Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by PureTech Health plc

< Previous 1 2 3 4 Next >
PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Health: Notice of Results
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million
From PureTech Health plc
Via Business Wire
Tickers PRTC RPRX
PureTech to Present at the Barclays Global Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at the SVB Securities Global Biopharma Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Provides End of Year Report on Key Progress
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech’s LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ Platform
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at Two Upcoming Investor Conferences
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at the Jefferies London Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at the Morgan Stanley Global Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye Pharmaceuticals
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia
From PureTech Health plc
Via Business Wire
Tickers PRTC
Results of Annual General Meeting
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at the UBS Global Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
From PureTech Health plc
Via Business Wire
Tickers PRTC
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.